https://www.indianpharmapost.com/biocon-biologics-receives-fda-approval-for-biosimilar-aflibercept-for-yesafili-156662024-05-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/asg-opens-its-branch-of-super-specialty-eye-hospitals-in-noida-156672024-05-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/dupixent-late-breaking-data-from-notus-confirmatory-phase-3-copd-study-presented-at-ats-and-published-in-nejm-156682024-05-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/modular-atp-study-of-the-mcrm-system-meets-primary-safety-and-efficacy-endpoints-156692024-05-21T00:00:00+05:30always0.9